Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

FK 448

Known as: FK-448 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Piperazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
proteínas : III . Aplicação à insulina
Oral delivery systems for peptides and proteins: III. Application to insulin Insulin is an important therapeutic protein… 
Review
1998
Review
1998
The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins.
The peroral administration of peptide drugs is a major challenge to pharmaceutical science. In order to provide a sufficient… 
1988
1988
[Promoting effect of the chymotrypsin inhibitor FK-448 on the intestinal absorption of insulin in rats].
Highly Cited
1985
Highly Cited
1985
Promoting effect of the new chymotrypsin inhibitor FK‐448 on the intestinal absorption of insulin in rats and dogs
FK‐448 is a potent and specific inhibitor of chymotrypsin, which enhances the intestinal absorption of insulin in rats and dogs… 
1985
1985
EFFECT OF NEW CHYMOTRYPSIN INHIBITOR (FK-448) ON INTESTINAL ABSORPTION OF INSULIN
1984
1984
New synthetic inhibitors of chymotrypsin.
4-Substituted carbonylphenyl ester derivatives were prepared and their inhibitory effects on chymotrypsin, trypsin, thrombin… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE